GlassScriptPhysician profile
Jesse David Borys
NPI 1811419161
$11,758.55
in general payments reported to CMS, 2019-2025
29 companies · $2,295 in 2025
The $2,295 reported for 2025 was more than what 86% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,912 · 2020: $978 · 2021: $2,213 · 2022: $704 · 2023: $656 · 2024: $3,001 · 2025: $2,295.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,312 · Travel and Lodging: $2,326 · Long Term Medical Supply Or Device Loan: $313.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,311.91 |
| Travel and Lodging | $2,325.95 |
| Long Term Medical Supply Or Device Loan | $313.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Liberty Surgical INC. | $3,253.36 | 2019-2022 | |
| Treace Medical Concepts, INC. | $2,113.87 | 2023-2025 | |
| Smith+Nephew, INC. | $1,185.61 | 2020-2025 | Stravix, Stravix Pl, Grafix Pl |
| Arthrex, INC. | $977.70 | 2024 | |
| Novus Surgical Consultants | $573.72 | 2024-2025 | |
| Zimmer Biomet Holdings, INC. | $569.04 | 2019-2021 | |
| Organogenesis INC. | $556.38 | 2021-2024 | |
| Paratek Pharmaceuticals, INC. | $394.26 | 2023-2025 | Nuzyra, Xhance |
| Stryker Corporation | $367.77 | 2019-2022 | |
| Integra Lifesciences Corporation | $361.11 | 2019-2024 | Acell, Integra, Integra Dermal Regeneration Template |
| Abbott Laboratories | $285.56 | 2023 | Proclaim |
| Convatec INC. | $170.99 | 2023-2024 | |
| In2bones USA, LLC | $132.61 | 2020 | |
| Paragon 28, INC. | $132.00 | 2019-2024 | Phantom Intramedullary Nail |
| Kerecis Limited | $125.65 | 2021-2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $96.42 | 2021 | |
| Medtronic, INC. | $86.49 | 2025 | Inceptiv |
| Averitas Pharma INC. | $73.17 | 2023-2025 | Qutenza |
| Abbvie INC. | $57.38 | 2023-2024 | Dalvance |
| Kowa Pharmaceuticals America, INC. | $41.71 | 2023 | Seglentis |
| Depuy Synthes Sales INC. | $36.01 | 2024 | |
| Tactile Systems Technology INC | $34.52 | 2022-2024 | Entre Plus, Flexitouch Plus |
| Biocomposites INC | $33.83 | 2020 | |
| Ibsa Pharma INC. | $24.70 | 2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $18.33 | 2020 | |
| Orthofix Medical, INC. | $16.71 | 2025 | Physio-Stim |
| Solventum Corporation | $16.40 | 2025 | Activ.A.C. |
| Kci USA, INC. | $11.66 | 2022 | |
| Zyla Life Sciences, INC. | $11.59 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jesse Borys listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.